Synthetic hpGRF 1–40 stimulates growth hormone and inhibits prolactin secretion in normal children and children with isolated growth hormone deficiency-Reference-Cited by-同舟云学术

Synthetic hpGRF 1–40 stimulates growth hormone and inhibits prolactin secretion in normal children and children with isolated growth hormone deficiency

Published:1983-11 Issue:6 Volume:4 Page:929-933
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Pintor C,Fanni V,Loche S,Locatelli V,Cella S.G,Villa F,Minuto F,Corda R,Müller E.E

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference11 articles.

1. Potency and specificity of a growth hormone-releasing factor in a primate and in vitro;Almeida,1983

2. Effects of human pancreatic growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency;Borges;Lancet,1983

3. Effects of a growth hormone releasing factor in man;Gelato;J Clin Endocrinol Metab,1983

4. Growth hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release;Grossman;Lancet,1983

5. Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly;Guillemin;Science,1982

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sermorelin;BioDrugs;1999

2. Effects of Thyrotropin-Releasing Hormone and Its Metabolites, Cyclo(His-Pro) and TRH-OH, on Growth Hormone and Prolactin Synthesis in Primary Cultured Pituitary Cells of the Common Carp,Cyprinus carpio;General and Comparative Endocrinology;1998-09

3. Growth Hormone (GH) Response to Combined Pyridostigmine and GH-Releasing Hormone Administration in Patients with Prader-Labhard-Willi Syndrome;Hormone Research;1993

4. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: A double-blind, placebo-controlled study;The Journal of Pediatrics;1993-01

5. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH- releasing hormone-(1-44)-NH2;Journal of Clinical Endocrinology & Metabolism;1992-11-01